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ABSTRACT
Objective: Human antigen R (HuR) is a member of the RNA-binding proteins which is a critical factor in mediating the proangiogenic factors resulting 
in angiogenesis among the tumors. During inflammation and anoxic conditions, cytokine interleukin-1 (IL-1) was found to activate the HuR which, in 
turn, aids in upregulation or downregulation of the hypoxia-inducible factors (HIF) 1α. The present study was designed to study the correlative effect 
of the cancer drug docetaxel (Taxotere) on the expression levels of HuR and HIF1α using HeLa cell lines.
Materials and Methods: The drug was tested for cytotoxicity among the cancer cell lines using the lactate dehydrogenase and 3-(4)5-Dimethyl-
thiazol-zyl)-2, 5, biphenyl tetrazolium bromide assay. Gene expression and correlation were found by the real-time expression of the gene members 
under the treatment. The same study was also confirmed using the molecular docking tools to screen for the possible potential anticancer target.
Results: The drug was found to decrease the expression levels of the cytokine IL-1 along with the HuR proteins. This was also found to show a positive 
inhibition on the expression of HIF1α. The study was also confirmed using the molecular docking studies which are in accordance to the wet lab 
studies.
Conclusion: The present study confirmed that the two receptors might act as potential anticancer drug targets which might aid in designing more 
novel drugs.
Keywords: Human antigen R, Anticancer targets, Hypoxia-inducible factors 1α, Docetaxel.
INTRODUCTION
Cancer remains a major health problem in the world, both in developed 
and developing countries. The World Health Organization and World Bank 
estimate that 12 million people worldwide suffer from cancer annually 
and 7.6 million of them died [1]. The high incidence and mortality of 
cancer patients are currently due to low rate of the success of treatments. 
Various methods against cancer have been developed including surgery, 
radiation, immunotherapy, and chemotherapy. However, the success rate 
of the methods is still low due to its disadvantages [2]. This situation 
encourages the efforts to discover and develop novel anticancer drugs that 
more effective and sensitive without serious side effects [3]. Cancer cell 
proliferation occurs beyond normal limits, and it is uncontrolled. This is due 
to the disruption of cell cycle, the increase of angiogenesis, and suppression 
of apoptosis. Apoptosis is a form of cell death designed to eliminate 
unwanted host cells [4,5]. The process of apoptosis is programmed through 
a series of events involving a set of gene products. Apoptosis is responsible 
for physiological and pathological processes. In the pathological process, 
apoptosis plays a major role in tumor cell death [6].
Human antigen R (HuR), a ubiquitously expressed member of the 
embryonic lethal abnormal vision (ELAV) family of RNA-binding 
proteins, exhibits specific affinities for AU-rich elements-containing 
RNA sequences [7] in vitro which correlate with their in vivo decay 
rates, thereby implicating HuR in the proangiogenic factors mediated 
angiogenesis. Generally speaking, angiogenesis is initiated by hypoxic 
or inflammatory conditions [8,9]. Hypoxia and inflammation activate 
HuR function through modulation of HuR subcellular localization and 
RNA-binding activity [6]. Furthermore, another inflammation-related 
cytokine interleukin-1 [10] could also activate the function of HuR to 
stabilize a set of target mRNAs for the fulfillment of a certain process 
[11]. In turn, activated HuR stabilizes TNFα or promotes the translation 
of hypoxia-inducible factors (HIF) 1α through the ARE located in the 3’ 
UTR, forming a positive feedback [12,13].
Considering the multiple roles of HIF-1 in tumor progression and 
metastasis, there have been great interests in developing inhibitors 
targeting this pathway. It is clear that HIF-1α regulation pathway is 
a highly complex network involving several signaling cascades and 
overlapping mechanisms, each of which could serve as a promising target 
or step to intervene selectively [14]. It is not surprising that most of the 
reported HIF-1α inhibitors were originally discovered for targeting other 
endogenous molecules and later their HIF-1α inhibitory activity was 
recognized through some empirical testing. For this reason, there are 
no specific HIF-1α inhibitors [15] currently and developing specific HIF-
1α inhibitors in hypoxic tumors represent a challenge. Taxotere is the 
trade name for docetaxel. In some cases, health-care professionals may 
use the trade name Taxotere when referring to the generic drug name 
docetaxel. Docetaxel is an anticancer (“antineoplastic” or “cytotoxic”) 
chemotherapy drug [16]. It has been approved in the treatment of breast 
cancer, non-small cell lung cancer, advanced stomach cancer, head and 
neck cancer, and metastatic prostate cancer [17]. Currently it is being 
studied to treat small cell lung, ovarian, bladder, and pancreatic cancers, 
soft tissue sarcoma and melanoma [19].
In the present study we aimed to screen for the potency of the drug 
Docetaxel against the hypothetical drug targets for pancreatic cancer. 
The study was conducted on the HeLa cell lines by estimating the gene 
expression levels of the possible drug targets under the drug treatment. 
The study was also confirmed using the in silico studies.
MATERIALS AND METHODS
The cell culture medium (Dulbecco’s Modified Eagle’s medium 
[DMEM]), fetal bovine serum (FBS), trypsin-ethylenediaminetetraacetic 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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acid (EDTA), penicillin and streptomycin were purchased from HiMedia 
labs. Human cervical carcinoma HeLa cells were obtained from Indian 
Academy degree college, Bangalore, India. The cell lines were cultured 
in the DMEM medium, supplemented with FBS (10%) and streptomycin 
(100 μg/mL). The cells were grown in CO2 incubator (Memmert, 
Germany) at about 37°C with 90% humidity and 5% CO2. Cells were 
subcultured when confluent using trypsin/EDTA. Docetaxel (Taxotere) 
CAS Number 114977-28-5 was purchased from Sigma-Aldrich. The 
drug was soluble in methanol and sued at varying concentrations for 
the study.
Primers design
Primer pairs were designed using Primer 3 software according to the 
protocol described by Sudhakar et al. [18] and were purchased from 
Sigma Aldrich. The specificity of the polymerase chain reaction (PCR) 
products and the primer pairs was checked in silico using BLAST 
(National Centre for Biotechnology Information) alignment tools.
3-(4)5-Dimethyl-thiazol-zyl)-2, 5, biphenyl tetrazolium bromide 
(MTT) assay
The current study was investigated to study the cytotoxic activity 
of the methanolic suspension of the selected drug on the HeLa using 
MTT assay [20]. The cells were treated with different concentrations 
(10, 20, 40, 60, 80, and 100 µg/ml) of the drug suspension to estimate 
the percentage cytotoxicity and half maximal inhibitory concentration 
(IC50) (50% growth inhibition). Colchicine (2.5 nM) was used as positive 
control throughout the study. The cells were plated at a cell density of 
about 5000–8000 cells/well and seeded in 96-well plates (HiMedia). 
After 24 h of incubation in the incubator, the cells were treated with 
different concentrations of the drug suspension. First, well without 
treatment was maintained as control. Following treatment, the cells 
were added with 20 μL of MTT solution (5 mg/mL in phosphate-
buffered saline [PBS]), and after incubation for 4–5 h, the media were 
removed and the cells were washed thrice with PBS. The plate was then 
vibrated for about 15 min before measuring the absorbance at 570 nm 
in each well using an enzyme-linked immunosorbent assay plate reader 
(Genetix, Bengaluru). Cytotoxicity was expressed as a percentage 
of growth inhibition and the concentration needed to inhibit the cell 
growth by 50% (IC50) was calculated. Percentage growth inhibition was 
calculated using the formula (1-[Optical density (OD) of treated/OD of 
control])×100. Each of the experiment was done using six replicates for 
each of the drug concentration and repeated in triplicates.
Lactate dehydrogenase (LDH) assay
Toxicity of the suspension was also assayed by estimating the 
concentration of the cytosolic enzyme LDH which is usually released 
into the media when the cell membrane gets damaged.[21] The cells 
were seeded according to the protocol as described in the previous 
section, and the drug suspensions at respective concentrations (0.5, 
1, 1.5, 2, 2.5, and 3 µg/ml) were added for treatment. Wells without 
treatment were served as control. Following incubation, after 24 h, the 
contents from each well were removed and estimated for the release 
of LDH into the media. The cytotoxicity was measured using the plate 
reader (Genetix) at 540 nm.
RNA extraction
The over confluent cell cultures (both treated 1.5 and 3 μg/ml and 
controls) were used in the extraction process. Total RNA was then 
extracted using an RNeasy Mini Kit (Qiagen 74104). The experiment 
was conducted based on the instructions mentioned in the kit.[22] 
The trypsinized cells after suspending in 2 ml of PBS were pelleted 
down by centrifuging at 6000 rpm for 5 min. The pellet obtained was 
Table 1: The details of primers used in the RT-PCR
Gene Sequence (5’–>3’) Length GC% Product
HuR FW GAGGTAGGGACCACCAGGAT 20 60.03 888
RV ACTTGCTCTTTTTCTCTTGGCAG 23 59.68
HIF-1A FW TGACCTGCTTGGTGCTGATT 20 59.89 208
RV GCGCTGAATCTTTGCTATGG 20 57.6
HuR: Human antigen R, HIF: Hypoxia-inducible factors, RT: Reverse transcription, PCR: Polymerase chain reaction, FW: Forward, RV: Reverse
Fig. 1: The percent inhibition values in 3-(4)5-Dimethyl-thiazol-
zyl)-2, 5, biphenyl tetrazolium bromide assay. All the values were 
average of triplicates and the values are expressed as value±standard 
error. All the measurements were normalized to control (0%)
Fig. 2: The half maximal inhibitory concentration values in 
3-(4)5-Dimethyl-thiazol-zyl)-2, 5, biphenyl tetrazolium bromide 
assay. All the values were average of triplicates and the values are 
expressed as value±standard error
Fig. 3: The percentage of lactate dehydrogenase (LDH) released 
from HeLa cells following 24 h exposure in LDH assay. All the 
values were average of triplicates and the values are expressed as 
percentage control values±standard error. All the measurements 
were normalized to control (0%)
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then resuspended in 560 μl AVL buffer and 560 μl chilled ethanol. The 
contents were mixed thoroughly and centrifuged again at 8000 rpm for 
about 1 min to facilitate the RNA to bind to the column. The column 
was then washed with 700 μl of wash buffer and centrifuged at 15 s 
followed by incubation with 60 μl of AVE buffer. The RNA eluted was 
now collected in the 2 ml of collection tubes and stored at −20°C. The 
RNA quality was checked by the ultraviolet spectrophotometer and 
used for complementary DNA (cDNA) synthesis.
Reverse transcription (RT) PCR: cDNA synthesis
The cDNA synthesis was carried using the RT PCR kit using SuperScript 
TMII Reverse Transcriptase, 200 U/μl (HiMedia). In brief, 2 μg of the 
RNA obtained in the previous section was used as the starting reaction. 
The RNA concentration obtained was about 1.97 μg/μl. Hence, about 
1.12 μl of the total RNA was used in the reaction. Random primers and 
1 μl of RT enzyme were added mixed thoroughly, and the contents were 
incubated at 25°C for 10 min. Followed by the incubation at 70°C for 
45 min, the cDNA obtained was then stored and used for real-time PCR 
analysis.
Real-time PCR
Primers for real time (Table 1) were designed using primer3 software 
and were purchased from Sigma-Aldrich. The real-time PCR assay was 
then performed according to Deepak et al. using the iQTM SYBR Green 
Supermix (HiMedia). The primers (600 nM) and 1 μl of the RT products 
were used in the PCR assay, and the reaction was done in a total volume 
of 12.5 μl. All the reactions were carried out in duplicates and also run 
in parallel with its respective negative control, to confirm the positive 
amplification.
Expression of HuR and HIF1-A members in samples
Real-time quantification was carried on the sample (both control and 
treatment) in the Corbett Research cycler (Bio-Rad). The HuR primers 
(HUR) (forward: 5’ GGGGGCATTCTAAGTCCAGTGA 3’ and reverse: 5’ 
TATCCCGCTATCCC CCTACATTAT 3’; 509bp) and HIF1-A (HIFA) of about 
600 nM concentration were used for the amplification program. 1.1 μl 
of the RNA products were initially used, and the program was run for 
about 40 cycles at 92°C for 50 s, 64°C for 40 s, and with an elongation 
at 72°C for 60 s. The housekeeping gene glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) (forward: 5’ TGGAAAGCTGTGGCGTGAT 3’ and 
reverse: 5’ CCCTGTTGCTGTAGCCGTAT 3’; 395bp) was also amplified 
along with the respective gene of interest for a comparative analysis 
of the mRNA expression. The comparative analysis of the relative 
levels of mRNA of the test samples (including control) was quantified 
using ΔΔCt method. The Ct values obtained for the gene of interest were 
normalized to its housekeeping gene.
Docking studies
Software such as SWISH Model, swish PDB viewer, ACD ChemSketch, 
Rampage, Argus Lab 4.0.1, and PATCHDOCK were used in the docking 
studies. HUR and HIF1-A receptors were used in the present context, and 
a model study to dock or inhibit the receptors were aimed at. Human-
like antigen R and hypoxia-inducible factor 1 alpha (NC_000014.9) were 
taken from the National Center for Biotechnology Information Entrez 
database. Homology modeling was done using SWISH Model freeware 
and the best template was chosen for the docking study. The models 
selected were further analyzed on PatchDock for docking studies.
RESULTS AND DISCUSSION
MTT assay
All the measurements were normalized to control (without treatment) 
and were considered as 0%. Our study confirmed that the treatment of 
the cells with the drug suspension at 10μg/mL showed proliferation 
activity but was very negligible when compared to the positive control 
and was found to be dose dependent. The activity of the drug was also 
found to positive when compared to colchicine and negative control. 
These values indicate that the drug suspension was equally potent to 
Fig. 4: Images of quantification curves of the expression of gene 
members. Left: Glyceraldehyde-3-phosphate dehydrogenase 
housekeeping gene; Middle: Human antigen R gene expression 
(dark line: Treatment and light line: Control); Right: Hypoxia-
inducible factor A gene expression (Dark line: Control and light 
line: Treatment). Ct values are average of duplicates
Fig. 5: The 2−∆∆Ct values for the gene members obtained from the 
real-time polymerase chain reaction. All the experiments were 
average of duplicates
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positive control. The IC50 values were found to 38.8 and 23.56 for the 
drug and positive control, respectively (Fig. 1 and Fig. 2).
LDH assay
Drug-induced membrane damage on HeLa cell lines was assayed 
by LDH release. After incubation, the amount of LDH release was 
calculated in comparison to the negative control (OD 0.01). Our results 
reported that, relative to untreated cells, the release was found to 
be dose dependent and the results were in accordance to MTT assay 
(Fig. 3). At an initial concentration, the release was very negligible when 
compared to colchicine and negative control. After 24 h of incubation, 
the drug suspension showed a significant increase in the LDH release 
relative to the control after 1 µg/ml. At a concentration of 3 µg/ml, the 
percentage release was found to 71±19.4 and 92±13.4% for drug and 
positive control, respectively (p<0.05).
Expression of gene members
All the results obtained are normalized to housekeeping gene (GAPDH), 
to reduce the differences, that usually occurs between the samples. The 
level of mRNA expression of each gene member (GAPDH, HUR, and 
HIFA) was studied separately. The sample with the lower ∆∆Ct values 
was taken as calibrator, and the remaining samples were relatively 
compared with that calibrator. The Ct values of the housekeeping gene, 
HUR, and HIFA were found to be 11, 21, and 18, respectively. Based on 
the Ct values, the Ct values of the samples (treatment with the drug) 
were normalized to the housekeeping gene (GAPDH). The GAPDH gene 
expression was considered as 100%. From the studies and calculated 
2−∆∆Ct values, it was observed that the HUR gene was under expressed 
when compared to the control and HIFA. Both HUR and HIFA were 
under expressed in the treatment than the control (Fig. 4 and Fig. 5). 
HUR gene was 64 times under expressed in the treatment and HIFA was 
16 times under expressed on treatment.
Cell cycle distribution
Cell cycle distribution by fluorescence-activated cell sorting (FACS) 
analysis was done using HeLa cell lines to find out whether the drug 
suspension exerted any anticancerous effect by inducing the cell 
cycle arrest. The experiment was followed according to Kaur et al. In 
brief, approximately 1×106 cells (HeLa) were plated in a 6-well plate 
containing 2 ml of complete DMEM. Following incubation for 24 h, cells 
were treated with or without (control) drug suspension at varying 
concentrations of 20 and 40 µg/ml. 20 µM of colchicine was used as 
positive control and 1% dimethyl sulfoxide as negative control (1% in 
DMEM media), the cells were collected and centrifuged at maximum 
speed of 5 min at RT, and the pellet was collected. The pellet was 
resuspended in 1×PBS and fixed overnight at 4°C in a 2 ml of fixing 
solution (20% PBS in 70% ethanol). The cells were then pelleted by 
centrifuging at 4000 rpm for 10 min (RT). The pellet was washed with 
cold 1×PBS and incubated for 15 min (RT) in 500 µl of propidium iodide 
(PI) solution containing 0.05 mg/ml PI and 0.05 mg/ml RNaseA in PBS. 
The percentage of cells or viability in various stages of the cell cycle in 
both treatment and controls was determined using FACS Caliber (BD 
Biosciences, San Jose, CA).
Cell cycle analysis
Our results of cell cycle analysis by flow cytometry in case of HeLa cell 
lines indicate that the drug suspension has significantly arrested the 
Fig. 6: The cell cycle analysis results. 1% dimethyl sulfoxide was used as a negative control. All the values are average of triplicates
Fig. 7: Images of the drug and receptors. Images were as viewed from Arguslab. Left: Drug molecule; middle: Human antigen R 1 receptor; 
right: Hypoxia-inducible factors 1A receptor
Fig. 8: Images of the solutions obtained from the PatchDock. 
Images were as viewed under Arguslab
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G2M phase of cell cycle. The cell cycle arrest in G2M phase was found 
to be 33.82±0.05% and 42.86±0.03% at 20 and 40 µg/ml, respectively, 
when compared to positive control (80.83±0.02%). The arrest was 
found to be 11.45±0.33%. The results confirm that the drug is a potent 
inhibitor for cancer and can arrest the cell division and stops cell 
proliferation very effectively (Fig. 6).
Docking studies
From the PatchDock results, the potent action of the drug toward the 
drug targets was confirmed. About four models were designed using 
SWISS model for each target. Of all the 8, only one target was selected, 
for which the patch dock score was high. The scores of model HUR and 
model HIFA were 4872 and 4716, respectively (Figs. 7 and 8). These 
two seems to be better fit than the other models.
CONCLUSION
Based on the significant findings from this work, it was confirmed that 
the drug was as potent as colchicines on the HeLa cell lines. Although 
the drug was being used in the clinical settings, no data were reported 
of its molecular validation. The two drug targets in the present study 
also confirm their possible role as anticancer drug targets which can be 
studied further. Even from in silico studies, it was found of the possible 
role of the receptors as novel drug targets and likely the drug Docetaxel 
might act on them.
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